This Week In HRV - Episode 43

[00:00:00] Welcome to this Week in Heart Rate Variability, the podcast where we take the latest peer reviewed research on autonomic function and bring it to life. Not just summarizing what studies found, but exploring what those findings mean, why they matter, and how they connect to the broader science of human health and resilience. [00:00:19] I'm your host and each week we work through new research together, holding it up to the light, turning it over, and asking the questions that move it from abstract data to genuine understanding. [00:00:30] Before we begin, the standard and important reminder Everything discussed on this podcast is intended for educational and informational purposes only. We are exploring research, not prescribing treatment. If you have questions about your own health, cardiovascular, neurological or otherwise, please consult a qualified healthcare professional who knows your individual circumstances. [00:00:53] Now let me walk you through what we're covering today so you have a clear sense of the shape of this episode. Before we get into the details, we have four studies, and while they come from very different clinical domains addiction medicine, cardiology, adolescent health, and pain science, they share something important. Each uses heart rate variability as a lens to examine a health question that matters to an enormous number of people. And each one, in its own way, challenges us to think more carefully about what autonomic function tells us, how we measure it, what we do with what we find, and critically, what we might be missing. When we approach autonomic assessment with too narrow a frame, we begin in the world of addiction medicine and recovery. Substance use disorder treatment is one of the most complex therapeutic challenges in modern medicine, and it is a domain where the integration of physiological monitoring with psychological assessment has enormous potential, but also genuine complexity that is only beginning to be understood. A new study followed individuals through their first month of residential treatment, tracking both wearable derived physiological data and self reported mental health in parallel, and found something that clinicians and researchers in this space need to hear clearly. The body and the mind do not always recover together. Heart rate variability and resting heart rate may be moving in a favorable direction while the patient is still struggling psychologically or the reverse. This dissociation is not an anomaly or a measurement artifact. It appears to be a genuine feature of early recovery, and it has direct implications for how we monitor, support and communicate with people at the most vulnerable stage of their healing. From addiction medicine, we move into cardiology, specifically to the frontier where heart failure research intersects with circadian biology. [00:02:50] We have known for years that heart rate variability is reduced in heart failure, but a new study asks a more refined and more interesting question. Is it just the level of autonomic function that is disrupted in these patients? Or is it also the rhythm? The circadian architecture of autonomic tone, the natural oscillation of sympathetic and parasympathetic activity across the 24 hour cycle turns out to be significantly disrupted in patients with cardiac remodeling in ways that go beyond what standard short term measurements can reveal. The blunting of the day night amplitude of heart rate variability and the disruption of its timing may carry diagnostic and prognostic information that clinicians are currently missing entirely. Our third study takes us into exercise science and adolescent health with one of the largest population based samples I have come across in a heart rate variability study is in quite some time, nearly 3,400 young men, all assessed at military call up in Finland. [00:03:53] The central question is how physical activity and body weight interact to shape vagal autonomic function in young people. The answer is more nuanced than the straightforward narrative of exercise good, obesity bad. And the specific finding about where the autonomic benefits of physical activity are greatest has has real implications for how we talk about exercise, particularly with adolescents who have obesity. And our fourth and final study is a systematic review that makes a case that most clinicians have not yet fully reckoned with that chronic low back pain is not simply a musculoskeletal condition but a systemic one with a clearly documented autonomic signature and a plausible biological pathway linking it to elevated risk of coronary artery disease. [00:04:40] The evidence is not yet definitive, and the authors are appropriately cautious about its certainty, but the consistency of the signal across 10 independently conducted studies warrants serious clinical and research attention. Four studies let's get into the first one. To appreciate what this study did and why it matters, we need to begin with the biological and clinical context of early recovery from substance use disorder. Because that context is not incidental, it is essential to interpreting the researcher's findings and why those findings carry the weight they do. Substance use disorder is not simply a behavioral condition. It is a condition that involves profound, often prolonged, and in some cases permanent disruption of the central and peripheral nervous systems, including the autonomic nervous system. The precise nature of those disruptions depends heavily on on the substance or substances involved. Opioids, alcohol, stimulants, cannabis, and sedative hypnotics each affect autonomic tone through distinct pharmacological mechanisms, and the acute withdrawal profiles of these substances are correspondingly different. But despite this heterogeneity, several common patterns tend to emerge across the landscape of active addiction and early withdrawal. Resting heart rate is frequently elevated in individuals with active substance use disorders and reflecting a state of chronic physiological arousal that is driven by the interplay of substance pharmacology, disrupted sleep, nutritional deficiencies, psychological stress, and in many cases, co occurring physical health conditions. The autonomic nervous system in active addiction is operating in a chronically sympathetically dominant state, a state of persistent physiological alert that has been normalized over months or years of use. [00:06:31] Heart rate variability, particularly the vagal or parasympathetic component, is typically suppressed in this context, sometimes markedly so. This suppression reflects a nervous system that has been deprived of the conditions that normally sustain a healthy parasympathetic restful restorative sleep, adequate nutrition, physical safety, psychological equilibrium, and freedom from the direct pharmacological effects of substances and that alter autonomic signaling. When someone enters residential treatment and ceases substance use, the process of autonomic recalibration begins. It does not begin all at once and it does not proceed uniformly. Resting heart rate typically begins to fall within the first days to weeks of abstinence as the acute physiological stress of active use and withdrawal resolves. Heart rate variability typically begins to rise as parasympathetic tone gradually recovers, but the timeline of this recovery varies considerably depending on the substances involved, the duration and severity of use, the individual's baseline physiological resilience, and a host of other biological and contextual factors. In some individuals, meaningful autonomic recovery can be observed within a month of treatment entry. In others, suppressed parasympathetic tone persists for months or longer than reflecting deeper neurobiological changes that require more time and sustained recovery to resolve. Against this background, the study examined here posed a deceptively simple question in its framing but genuinely complex in its implications. [00:08:08] When we monitor both the physiological and psychological trajectories of individuals in early recovery, do these two domains move together? When the body's autonomic metrics improve, does the person also report feeling better? [00:08:24] And when self reported stress, anxiety, and depression are declining, does the physiology reflect that improvement? This study was published in Frontiers in Psychiatry and is titled Tracking the Longitudinal Course of Physiologic and Mental Health Functioning among Individuals in Substance Use Disorder Treatment. [00:08:43] The authors are Wendy and Sulaco, Charlotte Clapham, Brett Galeno, Jamie Mayo, Barney, Brianna Billings, Jennifer D. Ellis, J. Gregory Hoboman, Andrew S. Huhn, Vadim Zipunikoff, and Jill A. Rabinowitz. The study enrolled 59 participants who were undergoing residential treatment for substance use disorder. Each participant wore a photoplethysmography HRV device continuously from the time they entered treatment until the end of their first month. [00:09:12] Photoplethysmography is the optical sensing technology used in most consumer grade wearables. It works by shining light, typically at infrared or green wavelengths, onto the skin surface and measuring the variation in light absorption as blood volume changes with each heartbeat. From this pulsatile signal, the device estimates both resting heart rate and heart rate variability. It is worth being precise about what this means for the data's quality. Photoplethysmography derived heart rate variability is not identical to electrocardiography derived heart rate variability which remains the gold standard. Photoplithysmography is more susceptible to motion artifacts and signal noise and its estimates of certain heart rate variability Frequency components, particularly high frequency power, which reflects respiratory linked vagal modulation, can deviate meaningfully from electrocardiographic reference measurements depending on the device measurement conditions and the individual skin characteristics in perfusion. [00:10:13] That said, a growing body of validation research has found reasonable agreement between photoplethysmography derived and electrocardiography derived heart rate variability metrics under conditions of rest and control measurement. In a residential treatment setting where continuous electrocardiographic monitoring would be logistically impractical and carry its own clinical connotations that could affect participant behavior and study validity, photoplithysmography represents a pragmatic and ecologically valid approach, one that allows passive, unobtrusive continuous monitoring throughout the observation period. [00:10:50] Alongside the continuous wearable monitoring, participants completed at least two structured mental health assessments during the same period. These assessments captured self reported stress, anxiety symptoms and depressive symptoms using validated questionnaire instruments. [00:11:07] The decision to administer at least two assessments rather than simply a baseline and an endpoint was important for capturing change over time, not just a static comparison, and it was the foundation for the longitudinal analysis the team conducted. The analytical approach centered on linear regression models to examine concurrent longitudinal associations between changes in physiological metrics and changes in mental health scores over the observation period. [00:11:36] Critically, and this is the methodological decision that makes the study genuinely valuable beyond a simple descriptive exercise, the team also conducted subject level analysis examining the distribution of individual recovery trajectories and characterizing the heterogeneity and how different individuals physiological and psychological changes related to one another. [00:11:59] This distinction between group level and subject level analysis is fundamental. Group level analysis tells you what the average person in the study did. Subject level analysis tells you how much variation exists around that average and in a population as diverse as people in early substance use disorder recovery, that variation is not noise to be averaged away, it is the signal at the group level. The findings are genuinely encouraging, both physiological and Mental health metrics showed favorable trends. Over the first month of treatment, resting heart rate tended to decrease consistent with the resolution of withdrawal related autonomic arousal and the beginning of parasympathetic recovery. Heart rate variability tended to increase consistent with the same process. [00:12:46] Self reported stress, anxiety, and depressive symptoms all tended to improve across the group. Taken at face value and reported without the subject level analysis, this would be a reassuring set of findings suggesting that early residential treatment produces parallel coordinated improvement across physiological and psychological domains. But the subject level data tells a considerably more complicated story. Among participants whose resting heart rate decreased, the subgroup showing favorable physiological change by this metric, only 39% corresponding to 23 of the 59 participants also showed concurrent decreases in self reported stress 42% corresponding to 25 participants showed concurrent decreases in anxiety 53% corresponding to 31 participants showed concurrent decreases in depression. Participants with increasing heart rate variability showed similar patterns of dissociation. In other words, even among participants who were improving physiologically according to wearable metrics, the majority were not improving across all three dimensions of self reported mental health. [00:13:57] Let's be precise about what this means and what it does not mean. It does not mean that physiological improvement is meaningless or that wearable monitoring is uninformative in this setting. It means that physiological and psychological improvement are not reliable proxies for one another in early recovery, that a person can be improving on one dimension while not yet improving on the other, and that these two trajectories appear to operate with meaningful independence and at the level of the individual. Several explanations for this dissociation are worth exploring. The first is temporal. Physiological and psychological recovery may genuinely operate on different timescales, and one month may simply be too early to see their trajectories converge. Autonomic recovery can begin within days of abstinence as the direct pharmacological suppression of parasympathetic tone by substances is removed. Psychological recovery from depression that may have been present for years, from anxiety disorders with deep neurobiological roots from the chronic psychological stress of addiction and its consequences often requires sustained therapeutic engagement, the rebuilding of social structures, and gradual neuroplastic changes in circuits governing mood and stress regulation. [00:15:14] These processes unfold over months and years, not weeks, and and the one month window of this study may not be sufficient to capture their early emergence. The second explanation concerns the domains of measurement. Photoplethysmography captures cardiac autonomic tone as expressed in resting heart rate and heart rate variability, but the subjective experience of stress, anxiety, and depression is mediated by a much broader set of neurobiological systems, the hypothalamic pituitary adrenal axis, the limbic system, prefrontal amygdala circuits governing emotional regulation, the serotonergic and dopaminergic systems that are profoundly disrupted by substance use and require extended time to recalibrate. A wearable device measuring cardiac signals captures one slice of this complex landscape. The self reported mental health measures capture a different slice. [00:16:11] It would be surprising if they correlated perfectly because they are measuring genuinely different things that are connected but not identical. [00:16:19] The third explanation is the genuine heterogeneity of the population. [00:16:24] People entering substance use disorder treatment present with vastly different biological histories, different substances and durations of use, different psychological comorbidities, different social circumstances, and different neurobiological resilience profiles. [00:16:40] Some individuals may show rapid parallel recovery across both physiological and psychological domains. Others may show physiological recovery that outpaces psychological recovery. Still others may experience psychological improvements, perhaps through the structure and social support of the residential environment, without yet showing corresponding physiological changes. [00:17:03] Understanding which individuals fall into which categories and what predicts those trajectories is clinically important and a research question that requires larger studies with longer follow up and richer characterization of the participant population. [00:17:18] The methodological limitations of this study are real and should be stated clearly. 59 participants are a modest sample size for a longitudinal study seeking to characterize individual level trajectories, and it comes from a single residential facility, limiting generalizability across different treatment settings, populations, and substance profiles. The study does not stratify its findings by primary substance, which matters because the autonomic recovery trajectories of opioid use disorder, alcohol use disorder, stimulant use disorder, and polysubstance use are distinct and may show very different relationships between physiological and psychological changes. The absence of a control group means that we cannot attribute the observed changes to the treatment itself versus the simple removal of substances, the structure of the residential environment, the passage of time, or other contextual factors that could independently produce improvements in both domains. Despite these limitations, the contribution of this study is clear and important. [00:18:22] It is one of the first to examine concurrent longitudinal trajectories of wearable derived physiological metrics and validated mental health assessments in a residential substance use disorder treatment context. [00:18:35] Its finding and das ay toao that these domains do not reliably co move at the individual level even when they trend in the same direction at the group level has direct and immediate implications for how treatment programs design and interpret their monitoring protocols. Wearable physiological monitoring is increasingly adopted in addiction treatments and settings, and the assumptions about what that monitoring tells us need to be grounded in empirical evidence like this. The evidence suggests that the wearable is telling part of the story, an important part, but not the whole story, and that parallel independent monitoring of psychological well being is not optional but essential for clinicians. Do not interpret an improving physiological signal as evidence that a patient in early recovery is doing well psychologically. [00:19:22] Do not interpret a stable or improving self report as evidence that physiological recovery is on track. Assess both independently and with instruments appropriate to each domain. [00:19:33] For researchers, the precision recovery medicine agenda, identifying which patients show which recovery trajectories and intervening accordingly depends on the kind of individual level trajectory data this study has begun to generate. [00:19:47] Larger, longer substance stratified studies will be needed to move this work forward. We turn now from addiction medicine to cardiology and specifically to a study that I believe represents one of the more methodologically sophisticated contributions to the heart failure autonomic literature in recent memory. Not because it overturns what we know, but because it asks a better question and uses the right tools to answer it. [00:20:13] The established scientific context is heart failure is associated with reduced heart rate variability. This has been documented across dozens of studies spanning more than three decades of research. [00:20:25] Reduced heart rate variability and heart failure reflects a progressive deterioration of autonomic regulation, specifically a withdrawal of parasympathetic modulation and a dominance of sympathetic tone that becomes increasingly pathological as the condition advances. [00:20:41] Reduced heart rate variability and heart failure is not merely a marker, it is prognostically significant. [00:20:48] Lower heart rate variability is associated with increased risk of sudden cardiac death, ventricular arrhythmias and all cause mortality and heart failure populations. This much is well established. What is less well established and what this study addresses is the temporal dimension of that autonomic dysfunction. [00:21:08] When we say that heart rate variability is reduced in heart failure, we typically mean that a short term measurement, often five minutes of resting heart rate variability yields lower values in heart failure patients than in healthy controls. But this framing treats autonomic function as a static quantity, as if the heart rate variability value you obtain at nine in the morning in a clinical setting is representative of a patient's autonomic profile across the full 24 hour cycle. It is not. The autonomic nervous system is a dynamic system whose output varies continuously across the day in response to activity, posture, meals, emotional state, stress, and most fundamentally, the endogenous circadian biological clock that orchestrates coordinated rhythmic variation across virtually every physiological system system in the body. [00:22:03] In a healthy individual, this circadian variation in autonomic tone is substantial and physiologically meaningful. During waking hours, sympathetic tone is relatively elevated, supporting alertness, metabolic activity and readiness for physical and cognitive demands. As the evening progresses and sleep approaches, the shift toward parasympathetic dominance begins during the night, particularly during slow wave sleep, the deepest and most restorative sleep stage. Parasympathetic activity surges, heart rate reaches its daily nadir, blood pressure dips and the cardiovascular system undergoes a period of relative hemodynamic unloading and repair. This nocturnal cardiovascular recovery is not a passive process. It is an actively regulated, hormonally coordinated and biologically essential phenomenon. [00:22:54] The loss of nocturnal blood pressure dipping, the so called non dipper pattern is a well established and independent cardiovascular risk factor. It is reasonable to hypothesize and this study provides evidence supporting the hypothesis that the parallel loss of nocturnal autonomic recovery may be equally or more important. [00:23:15] This study was published in Biomedicines and is titled Circadian Activity Disruption in Cardiac Remodeling Patients Underlies Autonomic Dysfunction in Heart Failure. The authors are Natalia Butrago Ricarte, Andre J. Riveros, Rafael Gonzalez Nino, Liliano Terro, Juan David Melendez, and Alain Riveros Rivera. To understand the study design, it helps to understand what cardiac remodeling means in this context. [00:23:43] Cardiac remodeling refers to the structural, functional and molecular changes that occur in the heart and in response to chronic pathological stress, whether from pressure overload, as in hypertension or aortic stenosis, volume overload as in valvular regurgitation, ischemic injury following myocardial infarction or other insults, including inflammatory cardiomyopathy and toxic exposures. These structural changes include alterations in ventricular chamber geometry. The heart enlarges, its walls thicken or thin depending on the nature of the insult, and its architecture shifts from the normal elliptical shape toward a more spherical form that is mechanically less efficient. [00:24:26] At the cellular level, cardiomyocytes hypertrophy and undergo molecular reprogramming. Interstitial fibrosis develops and the heart's electrical conduction system is affected at the autonomic level, cardiac remodeling is associated with progressive disruption of the sympathovagal balance that normally governs heart rate control, a disruption that is both a driver of further disease progression and a consequence of it in a pathological feedback loop. The study analyzed 24 hour electrocardiographic recordings from 86 patients meeting criteria for cardiac remodeling and 86 control subjects matched to allow meaningful group comparisons the use of full 24 hour ambulatory electrocardiographic recordings. Holter monitoring is the appropriate and necessary methodological choice for studying circadian autonomic dynamics. Short term recordings of five or 10 minutes, which are standard in research and clinical settings, can provide reliable estimates of average autonomic tone under control conditions, but they cannot capture how that tone varies across the day night cycle and they therefore cannot address the circadian question. [00:25:38] The heart rate variability analysis was conducted by computing multiple heart rate variability parameters from 5 Minute Black Man Harris windowed segments at each hour of the recording, generating a time series of hourly autonomic estimates spanning the full 24 hour period for each participant. The choice of Blackman Harris windowing is a methodological detail worth understanding. In frequency domain heart rate variability analysis, spectral estimation is performed on segments of the interbeat interval time series. [00:26:11] If the segment is simply extracted without windowing applied as a rectangular window, the abrupt edges of the segment create spectral leakage, a phenomenon in which power from one frequency band contaminates adjacent bands, reducing the accuracy of frequency domain estimates. [00:26:30] Blackman Harris windowing applies a tapering function to the segment, smoothly reducing the signal to zero at the edges and substantially reducing spectral leakage, thereby improving the reliability of frequency domain heart rate variability parameters. [00:26:46] The use of this windowing approach demonstrates methodological care that strengthens confidence in the frequency domain. Results Time domain, frequency domain, and nonlinear heart rate variability parameters were all computed, providing a multidimensional characterization of autonomic modulation at each time point. Nonlinear parameters, which capture the complexity and irregularity of the heart rate time series in ways that linear methods cannot, are particularly relevant in pathological populations as they tend to be sensitive to the breakdown of the normal dynamic complexity of cardiac regulation that accompanies disease. The critical analytical step was applying Kosanor modeling to the resulting time series hourly heart rate variability values. Kozner analysis fits a cozine function to rhythmic biological data and extracts three mathematically defined parameters. The midline estimating statistic of rhythm, abbreviated as mesore, represents the rhythm adjusted mean, the average level of the parameter across the full cycle, analogous to the midline of the oscillation. The amplitude represents half the total oscillatory range, the magnitude of the difference between peak and trough of the rhythm, and the acrophase identifies the clock time at which the peak of the fitted cozine occurs, the timing or phase of the rhythm. By applying Costner modeling to each heart rate variability parameter's 24 hour time series, the researchers could ask not only whether the average level of heart rate variability differed between groups the mesor comparison, but whether the magnitude and timing of its circadian variation differed the amplitude and acrophase comparisons. Age, sex and medication use were included as covariates throughout, which is essential in cardiac populations where beta blockers, renin, angiotensin, aldosterone system inhibitors, and antiarrhythmic agents all have known effects on heart rate variability. [00:28:48] The findings are internally consistent and build a compelling picture in the mesore comparisons. Patients with cardiac remodeling showed significantly reduced heart rate variability across multiple domains compared to controls, confirming the expected pattern of overall autonomic dysregulation, but the circadian findings are where the study's specific contribution lies. The amplitude of heart rate variability oscillations was significantly blunted in the cardiac remodeling group across multiple parameters, while healthy controls showed robust day night variation in autonomic tone, with heart rate variability rising substantially during nighttime sleep relative to daytime waking. Patients with cardiac remodeling showed a flattened profile with a substantially reduced difference between their daytime and nighttime autonomic states. [00:29:38] Additionally, acrophase analysis revealed phase shifts in several heart rate variability parameters in the cardiac remodeling group group, indicating that the timing of autonomic peaks was displaced relative to the expected pattern in healthy individuals. The physiological significance of these findings can be understood at two levels. At the immediate physiological level, the blunted nocturnal amplitude indicates that patients with cardiac remodeling are failing to undergo the normal restorative shift toward parasympathetic dominance during sleep. [00:30:11] The nocturnal surge in parasympathetic tone that healthy hearts experience every night is not just a reflection of rest it is an active biological process that supports myocardial recovery, modulates inflammatory signaling in cardioprotective directions, allows hemodynamic unloading of the ventricles, and reduces the risk of arrhythmia by stabilizing electrical conduction. A heart that is already structurally compromised by remodeling an already autonomically dysregulated heart during the day is being further deprived of its nightly recovery cycle at the systems level, phase shifts in autonomic timing suggest a broader disruption of circadian biological coordination. A decoupling of cardiac autonomic dynamics from the central circadian clock, which in healthy individuals orchestrates the precise timing of autonomic, hormonal, metabolic and immune rhythms as a coordinated whole. The therapeutic implications are multiple and worth thinking through carefully. If circadian autonomic disruption is a significant feature of cardiac remodeling and this study provides strong evidence that it is then interventions that specifically target circadian regulation deserve investigation in this population. [00:31:25] These might include chronobiologically informed exercise protocols that leverage the autonomic effects of physical activity at specific times of day optimization of sleep quality and architecture, which in heart failure patients is frequently disrupted by orthopenia, sleep disordered breathing and nocturia management of light exposure to reinforce circadian entrainment and, in due course, possibly pharmacological approaches targeting the molecular clockwork of circadian regulation. [00:31:57] Existing cardiac rehabilitation programs, which have demonstrated benefits for heart failure outcomes but have not typically attended to the circadian dimensions of their protocols might be revisited with this framework in mind. Clinically, this study raises the question of whether ambulatory 24 hour autonomic monitoring should be more routinely incorporated into the assessment of heart failure and cardiac remodeling patients. A five minute resting heart rate variability measurement in the clinic tells you something about a patient's average autonomic state on that particular morning. [00:32:30] It tells you nothing about their circadian autonomic profile, whether their nocturnal amplitude is preserved or blunted whether their autonomic rhythms are appropriately timed or phase shifted. Given evidence that these circadian features may have prognostic and therapeutic implications, the case for more comprehensive assessment approaches seems strong. The limitations of this study are real. [00:32:55] It is cross sectional, which means we can document the association between cardiac remodeling and circadian autonomic disruption. But we cannot from this data establish whether the disruption precedes and contributes to disease progression, whether it emerges as a consequence of structural changes, or whether both are parallel downstream effects of shared upstream pathology. [00:33:18] The sample of 86 patients per group, while adequate for the primary analyses, is relatively modest for detailed subgroup analyses, for example examining whether circadian disruption severity varies with the degree of left ventricular remodeling, ejection fraction, or functional class. The study does not report prospective outcomes data, so the prognostic significance of the circadian disruption documented here remains a hypothesis not yet a demonstrated clinical reality. These gaps define a clear agenda for future research. Now let's pause for a word from the sponsor that makes this show possible. [00:33:57] This week's episode is brought to you by Optimal hrv. The Optimal HRV app guides you through a standardized morning measurement protocol, building a reliable longitudinal baseline that makes tracking meaningful. Beyond passive monitoring, it includes biofeedback tools for real time training and autonomic regulation. [00:34:17] Actively working with your nervous system, not just observing it. [00:34:21] Optimal HRV is also hosting two upcoming professional development opportunities. The first is a BCIA aligned heart rate variability biofeedback training led by Dr. Ina Kazan carrying 16 APA continuing education credits, a rigorous foundation for clinicians looking to integrate heart rate variability biofeedback into practice. The second is a course on ethical principles and practice standards in clinical biofeedback, also BCIA aligned ideal for those pursuing certification or wanting a thorough grounding in professional standards. Registration links for both are in the show. Notes. Visit Optimal HRV to learn more. Our third study shifts the lens considerably away from disease states and toward a foundational question about development, lifestyle, and the physiological trajectories that shape cardiovascular health for an early age. The question is deceptively straightforward in young men how do physical activity and body weight interact to shape vagal autonomic function? [00:35:21] And does the benefit of physical activity for heart rate variability look the same regardless of body weight, or does it differ in magnitude across weight categories? These questions matter for reasons that go beyond academic interest. [00:35:35] Adolescence is a developmentally critical period for the autonomic nervous system. [00:35:40] Vagal control of heart rate continues to mature through the teenage years and into early adulthood, responding to the same environmental and behavioral inputsexercise sleep, stress, body composition that will continue to shape it across the lifespan. But the habits, physiological signatures, and body composition trajectories established during adolescence carry particular weight because they tend to persist. Young people who develop active habits during adolescence are more likely to remain relatively active in adult life. Young people who develop obesity during adolescence carry significantly elevated risks for cardiometabolic disease, including cardiovascular disease, type 2 diabetes, and hypertension that accumulate over subsequent decades. And young people whose vagal tone is already suppressed in adolescence, whether by sedentary behavior, excess adiposity, poor sleep, or their combination, are setting a lower autonomic baseline that may compound over time. This study was published in Physical Activity and Health and is titled Associations between Physical Activity, Body Mass Index, and Cardiac Autonomic Function in Adolescent Men. The authors are Jaco Tornber, Tina Ikehemo Kaisukaikonen, Rita Puku, Mario Kanurkala, Arto Hautala, Timo Jamsa, and Raja Korpelainen. The study enrolled 3,389 adolescent men with a mean age of 18 years and a mean body mass index of 23 who were attending mandatory military call ups in Finland. The Finnish Military call up system is a nationally standardized process that requires all young Finnish men to present for fitness and health assessments before determining their military service pathway. [00:37:29] This setting is methodologically important in a way that deserves explicit recognition. Volunteer based research samples the kind most commonly used in exercise science and health behavior research, are subject to systematic selection bias. The people who volunteer tend to be more health conscious, more physically active, and in better health than the general population. [00:37:51] The Finnish military call up sidesteps this problem almost entirely because participation is mandatory and population wide rather than voluntary. [00:38:01] The resulting sample is therefore substantially more representative of the actual distribution of physical activity levels, body compositions and health behaviors in the broader population of Finnish young men than any volunteer sample could be. This is a genuine methodological strength that increases the external validity of the findings. Heart rate variability was assessed using the root mean square of successive differences, universally abbreviated as rmssd for listeners who are newer to heart rate variability methodology. RMSSD is a time domain metric computed from the electrocardiographic or photoplethysmographic recording. As the square root of the mean of the squared differences between consecutive interbeat intervals, we what it captures physiologically is the moment to moment fluctuation in heart period, driven primarily by the vagus nerve's modulation of the sinoatrial node, the cardiac pacemaker. When the vagus nerve is tonically active and functionally responsive, consecutive heartbeat intervals vary substantially from one another, producing a high rmssd. [00:39:09] When vagal tone is suppressed or whether by sympathetic dominance, pharmacological effects, autonomic neuropathy, or the cumulative effects of sedentary behavior and metabolic dysregulation, this moment to moment variation diminishes and RMSSD falls. RMSSD is widely considered one of the most physiologically interpretable, practically measurable and clinically relevant single heart rate variability metrics and its use as the primary outcome in this study is appropriate and well justified. [00:39:41] It was measured using the Polar RS 800 heart rate monitor, a chest strap electrocardiographic device with well characterized validity for RMSSD measurement in research settings. Body composition was assessed using bioimpedance analysis with the InBody720 system which uses multi frequency electrical impedance to estimate fat mass, lean body mass, total body water and segmental body composition. [00:40:07] Standard anthropometric measures including waist circumference were collected using validated protocols. Physical activity was self reported using a standardized questionnaire and categorized into low, moderate and high levels based on reported intensity and weekly activity volume. Participants were stratified into three body mass index groups for normal weight encompassing body mass index values between 18.5 and 24.9, overweight between 25 and 29.9 and obesity defined as a body mass index at or above 30. [00:40:43] The findings emerge in two analytically distinct layers. The first layer is the most straightforward across all three body mass index, normal weight, overweight and obesity, RMSSD increased significantly with increasing physical activity level. The statistical significance was P 0.001 in all three groups independently. This finding replicates and extends to an adolescent population the well established adult literature showing that higher physical activity is associated with higher vagal heart rate variability, and it does so at a scale nearly 3,400 participants. That gives the finding exceptional statistical power. [00:41:29] The dose response relationship across activity categories evident consistently across all weight groups is meaningful. It is not simply that active people have higher RMSSD than inactive people, but that the association appears graded with moderate activity associated with intermediate RMSSD values between the low and high activity groups. The second analytical layer is more novel and more clinically interesting. [00:41:57] In the multivariable regression models examining how much variance in RMSSD was explained by the measured variables, the researchers found a systematic gradient across body mass index categories. In normal weight participants, physical activity alone explained 4% of RMSSD variance, a modest but statistically significant proportion. In overweight participants, physical activity together with waist circumference explained 5.9% of variance, and in participants with obesity, the combined model explains 7.4% of RMSSD variants. The increasing explanatory power of physical activity and the body composition variable of waist circumference across the weight categories from normal weight through overweight to obesity, tells us something important about the nature of the relationship between exercise and vagal tone. And in this population, the association between physical activity and RMSSD is not uniform across weight categories. It is strongest, at least as captured by the percentage of variance explained in those with the highest body mass index. Among adolescent men with obesity, being physically active is associated with a larger difference in vagal tone than being sedentary as in normal weight young men. The biological mechanisms that could produce this pattern are worth exploring in some depth and because they illuminate both the finding itself and its clinical implications. Obesity, particularly in its more severe forms, is associated with a cluster of physiological disturbances that each, through distinct pathways, suppresses vagal autonomic tone. Visceral adipose tissue is not metabolically inert. It is an endocrine organ that secretes a range of bioactive molecules including tumor necrosis factor alpha, interleukin 6, leptin and resistin. These adipokines and pro inflammatory cytokines promote a state of chronic low grade systemic inflammation that is directly toxic to vagal function, both through central effects on autonomic regulatory networks in the brain stem and hypothalamus and through peripheral effects on cardiac nerve terminals. Insulin resistance, which is common in obesity and is closely related to visceral adiposity, specifically has independent effects on autonomic balance, tipping the sympathovagal ratio towards sympathetic dominance through mechanisms involving catecholamine metabolism and impairment of baroreflex sensitivity. The increased mechanical load on the respiratory system imposed by excess adiposity can alter respiratory cardiac coupling, which is responsible for respiratory sinus arrhythmia. The physiological phenomenon most directly reflected in high frequency heart rate variability is and RMSSD and sleep disordered breathing, which is substantially more prevalent in individuals with obesity and which produces recurrent nocturnal hypoxia and arousal, has profound suppressant effects on vagal tone that persist into the waking day. Physical activity counteracts each of these pathways. Regular aerobic exercise reduces visceral adiposity and the inflammatory adipokine burden it generates. [00:45:13] Exercise training improves insulin sensitivity through multiple mechanisms including GLUT4 upregulation, muscle glycogen metabolism and adiponectin signaling. [00:45:23] Exercise training strengthens the baroreceptor reflex, the arterial blood pressure sensing mechanism that is one of the primary drivers of vagal cardiac control and has direct effects on cardiac vagaliferin fibers that improve their functional responsiveness. [00:45:39] Exercise improves sleep quality and reduces the severity of sleep disordered breathing in individuals with obesity. [00:45:46] When the baseline level of vagal suppression from all these obesity related mechanisms is higher, as it is in adolescents with obesity compared to their normal weight peers, the counteractive effect of regular physical activity may have more suppression to reverse and consequently may produce a larger detectable difference in in RMSSD between active and inactive individuals within this weight category. The public health implications of this gradient are significant and warrant clear communication. The dominant cultural and clinical narrative around physical activity and obesity frames exercised primarily as a weight management strategy, something people with obesity should do in order to lose weight. This framing is both scientifically incomplete and motivationally counterproductive. It is scientifically incomplete because the health benefits of physical activity are largely independent of weight change. [00:46:41] Improvements in cardiovascular risk factors, metabolic health, mental health and as this study demonstrates, autonomic nervous system function occurs with exercise training even in the absence of significant weight loss. It is motivationally counterproductive because it sets up an implicit expectation that exercise will produce visible weight loss that is frequently not met on short timescales, leading individuals to conclude that exercise is not working for them and to disengage from activity. The reframing supported by the data is physical activity is a direct and potent intervention for autonomic health and the autonomic benefits of regular exercise are not contingent on achieving or maintaining a particular body weight for young people with obesity specifically, who are often the least physically active, face the greatest barriers to activity participation and in whom the suppression of vagal tone is most severe. The case for vigorous exercise promotion as an autonomic health strategy communicated in autonomic health terms rather than weight loss terms is compelling. The methodological limitations of this study warrant a clear statement. [00:47:53] Physical activity was self reported, which is subject to well documented over reporting bias, social desirability effects and imprecision in capturing the intensity, duration and frequency of actual activity with the granularity needed to fully characterize the dose response relationship. The cross sectional design means that all associations reported are observational and point in time. The study cannot tell us what happens to RMSSD we when an individual increases their physical activity level, nor can it establish a causal direction to the observed association. [00:48:30] The sample is exclusively male and the degree to which the findings generalize to adolescent women is unknown and cannot be assumed given well documented sex differences in autonomic regulation, body composition and the hormonal milieu of adolescents. The variants explained by the models 4 to 7%, while statistically significant, is modest, indicating that physical activity and body mass indexed together account for a minority of the inter individual variability in RMSSD in this population. [00:49:03] Genetics, sleep quality, psychological stress, socioeconomic factors and other unmeasured variables likely account for the majority of the variants. [00:49:14] The strengths are substantial. The sample size of nearly 3,400 is remarkable for a heart rate variability study and confers exceptional statistical power. [00:49:24] The population based mandatory participation design minimizes selection bias in ways that no volunteer study can replicate. The use of a validated RMSSD measurement device with established research credentials adds measurement confidence and the body mass index. Stratified analysis, which is the analytical decision that generates the most important finding, is both methodologically sound and clinically motivated. Our final study today asks a question that sits at an intersection most clinicians have not been trained to consider. Is chronic low back pain a cardiovascular risk factor, not merely a condition that co occurs with cardiovascular disease because both are associated with aging and sedentary behavior, but a condition that may actively promote cardiovascular risk through a specific and biologically coherent mechanism, the sustained dysregulation of the autonomic nervous system. [00:50:20] The scale of the chronic low back pain problem is difficult to overstate. It is among the most prevalent conditions in the world, affecting upward of 500 million people at any given time across all age groups, socioeconomic strata and geographic regions. It is the leading cause of years lived with disability globally, consuming enormous quantities of healthcare resources and imposing profound economic and personal costs on individuals and societies. The standard clinical framework for chronic low back pain is musculoskeletal Diagnose the structural contributors where possible, manage pain through pharmacological and physical means, restore function through rehabilitation, and in selected cases intervene surgically. Autonomic assessment does not feature in this framework. Cardiovascular risk stratification does not feature in this framework. This review argues carefully and with appropriate epistemic humility about the current certainty of the evidence that both of these omissions may be consequential. [00:51:26] This study was published in QRIUS and is titled Autonomic Dysfunction as a Potential Pathophysiological link between Chronic Low Back pain and Coronary artery A Systematic Review. [00:51:40] The authors are Waqas, Alauddin, Rahul, Saxena, Arushi, Saxena, Sayali, Karner, Shri Sai, Santoshini, Sankaranarianan, Brishab R. Prajesh, Fahad, Idris, Shaikh iv, and Sumya Singh. [00:51:54] The methodological framework was the preferred reporting items for systematic reviews and meta analyses in its 2020 updated form, the current international standard for systematic review conduct and reporting. The database search was comprehensive, spanning PubMed and Medline, Scopus, Web of Science, Embase, the Cochrane Central Register of Controlled Trials, the Cumulative Index to Nursing and Allied Health Literature, ebascohost and Google Scholar, as well as gray literature sources covering the full period from database inception through January of this year. [00:52:31] Inclusion criteria specified studies evaluating autonomic or cardiovascular autonomic function in adult populations with chronic low back pain. [00:52:41] After structured duplicate screening and eligibility assessment, 10 studies met the inclusion criteria and were retained for analysis before examining what the studies found. The biological rationale deserves careful development because it is the conceptual spine of the entire review. [00:52:59] The reason this research question is coherent and why the findings should be interpreted as more than coincidence. Chronic pain from a nervous system perspective is a persistent threat signal. The experience of pain, particularly pain that is unresolvable, unpredictable, and associated with functional limitation, activates two overlapping physiological stress the hypothalamic pituitary adrenal axis, which coordinates the hormonal stress response through cortisol release, and the sympathoadrenal system, which activates the fight or flight arm of the autonomic nervous system through catecholamine release and direct sympathetic neural outflow. In the context of acute pain following genuine tissue injury, these activations are adaptive they mobilize the organism for urgent self protective action. But when pain becomes chronic, persisting for months or years beyond any acute tissue injury, these systems remain activated without the resolution that follows acute threat. [00:54:00] The result is a state of chronic sympathetic overdrive combined with suppressed parasympathetic tone, precisely the autonomic imbalance that that in other contexts we associate with elevated cardiovascular risk. [00:54:14] In the specific case of chronic low back pain, there is an additional mechanistic layer beyond simple stress activation. Chronic low back pain is increasingly understood not merely as a peripheral tissue problem but as a condition involving central nervous system sensitization. [00:54:30] Central sensitization refers to a state in which the central nervous system's processing of pain signals signals becomes amplified, the gain is turned up so that stimuli that would not normally be painful become painful, stimuli that are mildly painful become severely painful, and the spatial extent of pain sensitivity expands beyond the area of original injury. This sensitization is mediated by neuroplastic changes in synaptic transmission, receptor expression, and neural circuit connectivity in the spinal dorsal horn, brainstem, and cortical pain processing networks. These neural circuits do not operate in isolation. They are deeply interconnected with the brainstem nuclei and hypothalamic areas that govern autonomic regulation, including the nucleus tractus solitarius, the dorsal motor nucleus of the vagus nerve, and the rostroventrolateral medulla. Neuroplastic changes affecting central pain processing therefore have the potential to concurrently affect central autonomic regulatory regulation, producing autonomic dysfunction not merely as a downstream consequence of stress but as a direct result of reorganization and pain. Autonomic integration circuits the findings across the 10 included studies were notably consistent in their directional thrust. Most studies documented diminished vagal activity in individuals with chronic low back pain reflected in reduced heart rate variability across multiple metrics, time domain metrics including RMSSD and the standard deviation of normal to normal intervals, as well as frequency domain metrics reflecting high frequency parasympathetic power. Sympathetic overactivity was documented in several studies as reflected in elevated low to high frequency power ratios and elevated sympathetic skin conductance measures. Several studies reported impaired cardiovascular regulation behavior beyond heart rate variability alone, including impaired baroreflex sensitivity, the reflex arc through which blood pressure changes drive compensatory autonomic heart rate adjustments, and abnormal heart rate recovery following exercise, which is itself a vaguely mediated phenomenon with established prognostic significance in cardiovascular risk stratification. Several studies have also documented alterations in descending pain modulation and consistent with the central sensitization framework and supporting the hypothesis that autonomic and nociceptive dysregulation interact and are mutually reinforcing in chronic low back pain. The epidemiological component of the review is particularly striking. Population based evidence within the review pointed to elevated rates of coronary heart disease and myocardial infarction among individuals with chronic low back pain, independent of age and other obvious confounders. This epidemiological signal, observed consistently across multiple independent populations, does not establish causality, and the authors are appropriately careful not to claim it does. Multiple shared upstream factors, including sedentary behavior forced by pain and functional limitation sleep disturbance driven by pain psychological comorbidities including depression and anxiety, which are highly prevalent in chronic low back pain and independently associated with both autonomic dysfunction and cardiovascular risk and socioeconomic disadvantage, which is associated with both chronic pain and poor cardiovascular outcomes, could independently contribute to the epidemiological association without chronic low back pain directly causing heart disease. But the mechanistic plausibility of the autonomic pathway, combined with the epidemiological signal and the direct evidence of autonomic dysfunction in the included studies, builds a coherent case that demands serious scientific and clinical attention even if its final causal architecture remains to be fully established. [00:58:30] The interventional findings in the review, while limited in quantity and methodological rigor, point in an encouraging direction. Studies examining yoga based rehabilitation programs and spinal manipulative therapy in chronic low back pain populations found improvements in autonomic regulation, specifically increases in heart rate variability and other markers of vagal recovery following these interventions. The mechanisms through which these interventions might improve autonomic function are worth speculating about because they inform research hypotheses. Yoga based rehabilitation combines physical movement and strengthening, which has known autonomic benefits through the mechanisms discussed in the previous study with breathing practices, specifically, slow, deep controlled breathing that directly drive parasympathetic activation through the respiratory sinus arrhythmia mechanism and may have sustained effects on vagal tone through central neuroplastic changes. Spinal manipulative therapy may act through several potential pathways, including effects on paraspinal muscle afferent signaling, proprioceptive input to brainstem autonomic centers, and general relaxation and stress reduction effects. Neither intervention's autonomic benefits have been definitively characterized mechanistically, and neither has been tested in adequately powered randomized controlled trials with autonomic endpoints as primary outcomes. But the directional signal in the existing evidence is sufficiently consistent to justify those trials for clinicians who manage patients with chronic low back pain, which, given its prevalence, means virtually every primary care physician, physiatrist, orthopedic surgeon, pain specialist, and physical therapist in practice, the core message of this review is a reframing of what chronic low back pain is it is not only a condition of the spine and the musculature surrounding it. It is a condition of the nervous system, both the pain processing system and the autonomic system, with measurable systemic physiological consequences, including cardiovascular effects that are not addressed by standard musculoskeletal management approaches. This does not mean that every patient with chronic low back pain needs autonomic monitoring or cardiovascular risk stratification as part of their standard care care. The evidence is not yet mature enough to support that as a universal recommendation, but it does mean that for patients with severe, long standing, poorly controlled low back pain, particularly those who also have other cardiovascular risk factors, the potential contribution of autonomic dysregulation to their overall risk profile is worth considering clinically and worth discussing with the patient. [01:01:18] The limitations of this systematic review must be acknowledged with care. The certainty of evidence across the included studies ranged from low to moderate. This reflects the methodological heterogeneity of the underlying research differences in how chronic low back pain was operationally defined, differences in the autonomic measurement approaches used, differences in study populations, and the predominance of observational and cross sectional design that preclude causal inference. Only 10 studies met the inclusion criteria, which is a small evidence base for strong conclusions. The heterogeneity across studies precluded formal meta analysis, meaning the synthesis is qualitative and therefore inherently more dependent on reviewer judgment. [01:02:04] Future systematic reviews in this area will benefit from a growing body of more methodologically rigorous prospective and interventional studies that the current literature does not yet encompass. [01:02:16] Four studies, four clinical domains one episode Let me bring the threads together because the connections across this body of research are, I think, more than superficial. They reflect genuine convergence in what the autonomic literature is telling us right now about the nature of physiological health and the limits of how we have measured and understood it. [01:02:38] The first and most persistent theme across all four studies is the inadequacy of a single dimensional static assessment of autonomic function. The Substance Use Disorder study shows that a wearable physiological metric captures something real about recovery but does not capture the full picture of where a person is psychologically and that, assuming it does, leads to incomplete and potentially misleading clinical judgments. The cardiac remodeling study shows that a standard short term heart rate variability measurement captures average autonomic tone but misses the circadian architecture of that tone, its amplitude, its timing and the degree to which the normal day night recovery cycle is intact or disrupted. The Chronic Low Back Pain review shows that a musculoskeletal assessment misses the systemic, autonomic and cardiovascular dimensions of a condition that is affecting hundreds of millions of people. And the adolescent study, while not directly making a failure of assessment argument, shows that the relationship between lifestyle variables and autonomic function is moderated by weight status in ways that a simple population level correlation would obscure. In each of these cases, the lesson is the same. [01:03:55] The questions we ask and the measurements we take do not yet capture the full dimensionality of what is happening in the autonomic nervous system. Building richer, more temporally resolved, and more contextually integrated assessment frameworks is a priority for the field. [01:04:11] The second theme is the modifiability and plasticity of the autonomic nervous system. This is the thread of hope that runs through today's research and it deserves to be be named explicitly as it is easy to lose sight of it when we are deep in the complexities of pathophysiology and methodology. [01:04:29] The Substance Use Disorder study shows that even within the first month of residential treatment, physiological metrics trend toward recovery. The nervous system begins to respond when the conditions that were suppressing it are removed. The Adolescent Physical Activity Study shows that regular exercise is is associated with better vagal tone even in the most autonomically suppressed subgroup, young people with obesity, suggesting that the barriers to autonomic health in this population are not insurmountable. [01:04:59] The Back Pain review documents improvements in autonomic regulation following yoga and spinal manipulation, suggesting that effective treatment of the underlying pain condition may simultaneously restore autonomic balance. [01:05:14] The Cardiac Remodeling study, while not itself an intervention study, raises therapeutic hypotheses targeting the circadian architecture of autonomic recovery with genuine clinical promise. [01:05:26] Across all four studies, the autonomic nervous system emerges not as a fixed biological given, but as a dynamic and responsive system whose function can be steered in better directions by the choices we make regarding treatment, lifestyle and clinical monitoring. The third theme is the cross cutting importance of individual variability. The Substance Use Disorder study makes this point with particular force. Group level averages conceal individual level heterogeneity that is not noise but signal. The adolescent study shows significant population level associations that nonetheless explain only a modest fraction of the variance in any individual's vagal tone. The Circadian Heart Failure study and the Back Pain Review, while not foregrounding individual variability in their primary analyses, are implicitly pointing toward the same reality that patients within a diagnostic category are not physiologically interchangeable and then understanding why individuals differ in their autonomic profiles, their recovery trajectories and their responses to treatment is the frontier that precision medicine in this space needs to pursue. The autonomic nervous system connects everything. It connects the mind and the body, as the substance use disorder studies show so clearly. It connects the day and the night, as the circadian heart failure study illuminates. It connects movement and health at every age and every weight, as the adolescent study demonstrates. And it links pain and cardiovascular risk through mechanisms that are increasingly well characterized, even if not yet fully understood. [01:07:04] Each week on this podcast we see new evidence of the breadth and depth of what heart rate variability can tell us about human health and of how much work remains to be done to translate that signal into the clinical care that patients deserve. Thank you for being here this week. Share the episode with colleagues who would find it valuable. Show notes and study links are available wherever you listen to this podcast. Until next time, stay curious, stay rigorous and take care of your nervous system.